{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:27:36Z","timestamp":1777123656914,"version":"3.51.4"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,2,15]]},"DOI":"10.2169\/internalmedicine.0130-22","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T22:09:27Z","timestamp":1656972567000},"page":"601-604","source":"Crossref","is-referenced-by-count":3,"title":["Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases"],"prefix":"10.2169","volume":"62","author":[{"given":"Hajime","family":"Yasuda","sequence":"first","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"},{"name":"Department of Cell Therapy and Transfusion Medicine, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayako","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Pathology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"},{"name":"Laboratory for the Development of Therapies Against MPN, Juntendo University School of Medicine, Japan"},{"name":"Department of Advanced Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Gaulard P, Swerdlow SH, Harris NL, Sundstrom CS, Jaffe ES. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. IARC Press, Lyon, 2017: 462-464."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ishigaki S, Masaoka T, Kameyama H, et al. Methotrexate-associated lymphoproliferative disorder of the stomach presumed to be mucosa-associated lymphoid tissue lymphoma. Intern Med 57: 3249-3254, 2018.","DOI":"10.2169\/internalmedicine.0737-18"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rashidi A, Fisher SI. Primary adrenal lymphoma: a systematic review. Ann Hematol 92: 1583-1593, 2013.","DOI":"10.1007\/s00277-013-1812-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ohkura Y, Shindoh J, Haruta S, et al. Primary adrenal lymphoma possibly associated with Epstein-Barr virus reactivation due to immunosuppression under methotrexate therapy. Medicine (Baltimore) 94: e1270, 2015.","DOI":"10.1097\/MD.0000000000001270"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hanai S, Kobayashi K, Kawashima I, Ichijo M, Nakagomi D. Disappearance of bilateral adrenal tumours: immunodeficiency-associated lymphoproliferative disorder in a patient with rheumatoid arthritis. Rheumatology (Oxford) 60: e255-e257, 2021.","DOI":"10.1093\/rheumatology\/keab138"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kurita D, Miyoshi H, Ichikawa A, et al. Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors. Am J Surg Pathol 43: 869-884, 2019.","DOI":"10.1097\/PAS.0000000000001271"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kaji D, Kusakabe M, Sakata-Yanagimoto M, et al. Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases. Br J Haematol 195: 585-594, 2021.","DOI":"10.1111\/bjh.17824"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fujimoto K, Hatanaka KC, Hatanaka Y, et al. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases. Hematol Oncol 38: 799-807, 2020.","DOI":"10.1002\/hon.2790"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Singh D, Kumar L, Sharma A, Vijayaraghavan M, Thulkar S, Tandon N. Adrenal involvement in non-Hodgkin's lymphoma: four cases and review of literature. Leuk Lymphoma 45: 789-794, 2004.","DOI":"10.1080\/10428190310001615756"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zhou L, Peng W, Wang C, Liu X, Shen Y, Zhou K. Primary adrenal lymphoma: radiological; pathological, clinical correlation. Eur J Radiol 81: 401-405, 2012.","DOI":"10.1016\/j.ejrad.2010.11.026"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/4\/62_0130-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:25Z","timestamp":1715315485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/4\/62_0130-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0130-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"article-number":"0130-22"}}